This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_OTHER_OR_ILLDEFINED_SITES_EXALLC for full statistics.
Malignant neoplasm of other and ill-defined sites
C3_OTHER_OR_ILLDEFINED_SITES
benign neoplasm: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C76
Cause of death: ICD-9
195
Cause of death: ICD-8
195
Cancer registry: Topography ICD-O-3
C76
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
71
Check minimum number of events None
71
Include endpoints None
71
Remove individuals based on genotype QC
71
C3_OTHER_OR_ILLDEFINED_SITES
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and ill-defined sites
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of other and ill-defined sites (controls excluding all cancers)
- Secondary uncertain malignant neoplasm (controls excluding all cancers)
- Secondary uncertain malignant neoplasm
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 71 | 17 | 54 |
| Unadjusted prevalence (%) | 0.02 | 0.01 | 0.03 |
| Mean age at first event (years) | 68.22 | 68.47 | 68.14 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_OTHER_OR_ILLDEFINED_SITES – Malignant neoplasm of other and ill-defined sites
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of other and ill-defined sites
↥Endpoint not on priority list, no data to show.